OR2AK2
gene geneOn this page
Summary
OR2AK2 (olfactory receptor family 2 subfamily AK member 2, HGNC:19569) is a protein-coding gene on chromosome 1q44, encoding Olfactory receptor 2AK2 (Q8NG84). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 391191 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 69 total
- MANE Select transcript:
NM_001004491
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:19569 |
| Approved symbol | OR2AK2 |
| Name | olfactory receptor family 2 subfamily AK member 2 |
| Location | 1q44 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000187080 |
| Ensembl biotype | protein_coding |
| Entrez | 391191 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000366480
RefSeq mRNA: 1 — MANE Select: NM_001004491
NM_001004491
CCDS: CCDS31102
Canonical transcript exons
ENST00000366480 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001441818 | 247965233 | 247966386 |
Expression profiles
Bgee: expression breadth tissue_specific, 6 present calls, max score 89.77.
Top tissues by expression
121 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 89.77 | gold quality |
| bone marrow | UBERON:0002371 | 41.32 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 38.98 | gold quality |
| bone marrow cell | CL:0002092 | 38.80 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| sural nerve | UBERON:0015488 | 36.53 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| primary visual cortex | UBERON:0002436 | 33.88 | gold quality |
| prefrontal cortex | UBERON:0000451 | 33.65 | silver quality |
| mucosa of stomach | UBERON:0001199 | 33.59 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| frontal cortex | UBERON:0001870 | 31.16 | silver quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| tonsil | UBERON:0002372 | 30.64 | gold quality |
| right uterine tube | UBERON:0001302 | 30.36 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| urinary bladder | UBERON:0001255 | 29.37 | gold quality |
| liver | UBERON:0002107 | 29.34 | gold quality |
| blood | UBERON:0000178 | 28.93 | gold quality |
| monocyte | CL:0000576 | 28.86 | gold quality |
| leukocyte | CL:0000738 | 28.74 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 28.55 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| placenta | UBERON:0001987 | 27.78 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| spleen | UBERON:0002106 | 26.79 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.47 |
Regulation
Is transcription factor: no
Cross-species orthologs
14 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or2ak6 | ENSMUSG00000064044 |
| mus_musculus | Or2ak4 | ENSMUSG00000107677 |
| mus_musculus | Or2ak7 | ENSMUSG00000107711 |
| mus_musculus | Or2ak5 | ENSMUSG00000108265 |
| rattus_norvegicus | Or2ak4c | ENSRNOG00000065470 |
| rattus_norvegicus | Or2ak4e | ENSRNOG00000071794 |
| rattus_norvegicus | Or2ak6c | ENSRNOG00000072421 |
| rattus_norvegicus | Or2ak5d | ENSRNOG00000077365 |
| rattus_norvegicus | Or2ak4 | ENSRNOG00000080808 |
| rattus_norvegicus | Or2ak5b | ENSRNOG00000082313 |
| rattus_norvegicus | Or2ak4c | ENSRNOG00000085214 |
| rattus_norvegicus | Or2ak5f | ENSRNOG00000085553 |
| rattus_norvegicus | Or2ak5 | ENSRNOG00000086996 |
| rattus_norvegicus | Or2ak6e | ENSRNOG00000089309 |
Paralogs (92): OR2B6 (ENSG00000124657), OR13C9 (ENSG00000136839), OR13C4 (ENSG00000148136), OR2M5 (ENSG00000162727), OR10A5 (ENSG00000166363), OR2D2 (ENSG00000166368), OR2B2 (ENSG00000168131), OR2C1 (ENSG00000168158), OR13J1 (ENSG00000168828), OR10G3 (ENSG00000169208), OR10A3 (ENSG00000170683), OR10A4 (ENSG00000170782), OR10A2 (ENSG00000170790), OR13H1 (ENSG00000171054), OR2K2 (ENSG00000171133), OR2M4 (ENSG00000171180), OR10H2 (ENSG00000171942), OR10H5 (ENSG00000172519), OR10AD1 (ENSG00000172640), OR2Y1 (ENSG00000174339), OR10AG1 (ENSG00000174970), OR2T1 (ENSG00000175143), OR10P1 (ENSG00000175398), OR2T35 (ENSG00000177151), OR2M7 (ENSG00000177186), OR2T12 (ENSG00000177201), OR2T33 (ENSG00000177212), OR2AJ1 (ENSG00000177275), OR2T8 (ENSG00000177462), OR2G3 (ENSG00000177476), OR2G2 (ENSG00000177489), OR2B11 (ENSG00000177535), OR2D3 (ENSG00000178358), OR13D1 (ENSG00000179055), OR10A7 (ENSG00000179919), OR2Z1 (ENSG00000181733), OR2V2 (ENSG00000182613), OR10G7 (ENSG00000182634), OR2T29 (ENSG00000182783), OR2T34 (ENSG00000183310)
Protein
Protein identifiers
Olfactory receptor 2AK2 — Q8NG84 (reviewed: Q8NG84)
Alternative names: Olfactory receptor 2AK1, Olfactory receptor OR1-47
All UniProt accessions (1): A0A2C9F2M8
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_001004491* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
Pfam: PF13853
UniProt features (20 total): topological domain 8, transmembrane region 7, sequence variant 2, chain 1, glycosylation site 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NG84-F1 | 86.93 | 0.64 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 112–204
Glycosylation sites (1): 20
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 20 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP, SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, chr1q44, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, REACTOME_OLFACTORY_SIGNALING_PATHWAY, REACTOME_SENSORY_PERCEPTION
GO Biological Process (4): detection of chemical stimulus involved in sensory perception of smell (GO:0050911), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
160 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR2AK2 | FAM229B | Q4G0N7 | 522 |
| OR2AK2 | NPIPB9 | F8W1W9 | 504 |
| OR2AK2 | TMEM244 | Q5VVB8 | 447 |
| OR2AK2 | IQCF1 | Q8N6M8 | 432 |
| OR2AK2 | MMS22L | Q6ZRQ5 | 415 |
| OR2AK2 | APOL2 | Q9BQE5 | 414 |
| OR2AK2 | TMEM60 | Q9H2L4 | 378 |
| OR2AK2 | KICS2 | Q96MD2 | 321 |
| OR2AK2 | PCDHB13 | Q9Y5F0 | 321 |
| OR2AK2 | PCDHB6 | Q9Y5E3 | 314 |
| OR2AK2 | PCDHB14 | Q9Y5E9 | 314 |
| OR2AK2 | PCDHB4 | Q9Y5E5 | 311 |
| OR2AK2 | PCDHB15 | Q9Y5E8 | 311 |
| OR2AK2 | PCDHB10 | Q9UN67 | 311 |
| OR2AK2 | PCDHB9 | Q9Y5E1 | 311 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A2R8YED5, A6NM03, O14581, O60412, O76099, O95006, O95047, O95371, P34982, P34984, P47884, P58170, Q15619, Q15622, Q5TZ20, Q60883, Q60887, Q60891, Q6IFH4, Q7Z3T1, Q8N628, Q8NG84, Q8NG95, Q8NG98, Q8NG99, Q8NGA0, Q8NGA1, Q8NGA2, Q8NGQ5, Q8NGR9, Q8NGS1, Q8NGS2, Q8NGS3, Q8NGV0, Q8NGW1, Q8NGX1, Q8NH06, Q8NH80, Q8NHA4, Q95157
Diamond homologs: A3KFT3, A4D2G3, A6NH00, A6NL26, A6NM03, O43869, O76000, O76001, O76002, O95006, O95221, O95371, O95918, P0C7N1, P0C7T2, P23274, P23275, P34984, P59922, Q13606, Q13607, Q5TZ20, Q60880, Q60890, Q6IEZ7, Q6IF00, Q8N127, Q8N349, Q8N628, Q8NG75, Q8NG76, Q8NG77, Q8NG80, Q8NG81, Q8NG83, Q8NG84, Q8NG85, Q8NG97, Q8NGC0, Q8NGE5
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
69 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 58 |
| Likely benign | 6 |
| Benign | 5 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
293 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:247965640:GA:G | donor_gain | 1.0000 |
| 1:247965642:G:GG | donor_gain | 0.9900 |
| 1:247965481:TACAG:T | acceptor_gain | 0.9400 |
| 1:247965484:A:AG | acceptor_gain | 0.9300 |
| 1:247965485:G:GG | acceptor_gain | 0.9300 |
| 1:247965485:GTT:G | acceptor_gain | 0.9100 |
| 1:247965311:A:AC | acceptor_gain | 0.9000 |
| 1:247965387:G:GT | donor_gain | 0.8900 |
| 1:247965485:G:T | acceptor_gain | 0.8800 |
| 1:247965482:ACAG:A | acceptor_gain | 0.8700 |
| 1:247965432:A:AG | acceptor_gain | 0.8600 |
| 1:247965480:TTACA:T | acceptor_gain | 0.8600 |
| 1:247965483:CAG:C | acceptor_gain | 0.8300 |
| 1:247965484:A:T | acceptor_gain | 0.8300 |
| 1:247965388:A:T | donor_gain | 0.8100 |
| 1:247965484:AGTT:A | acceptor_gain | 0.7800 |
| 1:247965485:GTTG:G | acceptor_gain | 0.7800 |
| 1:247965485:GT:G | acceptor_gain | 0.7600 |
| 1:247965638:CAGA:C | donor_gain | 0.7500 |
| 1:247965913:TGAAG:T | acceptor_gain | 0.7300 |
| 1:247965432:AATAT:A | acceptor_gain | 0.7000 |
| 1:247965469:T:A | acceptor_gain | 0.6600 |
| 1:247965639:AGAG:A | donor_loss | 0.6600 |
| 1:247965641:AGT:A | donor_loss | 0.6600 |
| 1:247965642:G:A | donor_loss | 0.6600 |
| 1:247965643:T:TT | donor_loss | 0.6600 |
| 1:247965646:G:A | donor_loss | 0.6600 |
| 1:247965485:GTTGC:G | acceptor_gain | 0.6300 |
| 1:247965914:GAAG:G | acceptor_gain | 0.6300 |
| 1:247965639:AGA:A | donor_gain | 0.6200 |
AlphaMissense
2074 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:247966121:A:C | S264R | 0.910 |
| 1:247966123:C:A | S264R | 0.910 |
| 1:247966123:C:G | S264R | 0.910 |
| 1:247965905:T:C | F192L | 0.891 |
| 1:247965907:T:A | F192L | 0.891 |
| 1:247965907:T:G | F192L | 0.891 |
| 1:247965410:T:C | F27L | 0.880 |
| 1:247965412:T:A | F27L | 0.880 |
| 1:247965412:T:G | F27L | 0.880 |
| 1:247966127:T:C | F266L | 0.864 |
| 1:247966129:C:A | F266L | 0.864 |
| 1:247966129:C:G | F266L | 0.864 |
| 1:247965878:T:C | F183L | 0.863 |
| 1:247965880:C:A | F183L | 0.863 |
| 1:247965880:C:G | F183L | 0.863 |
| 1:247965980:A:C | S217R | 0.854 |
| 1:247965982:T:A | S217R | 0.854 |
| 1:247965982:T:G | S217R | 0.854 |
| 1:247965686:T:C | F119L | 0.849 |
| 1:247965688:C:A | F119L | 0.849 |
| 1:247965688:C:G | F119L | 0.849 |
| 1:247965908:T:C | F193L | 0.848 |
| 1:247965910:C:A | F193L | 0.848 |
| 1:247965910:C:G | F193L | 0.848 |
| 1:247965629:T:C | F100L | 0.847 |
| 1:247965631:C:A | F100L | 0.847 |
| 1:247965631:C:G | F100L | 0.847 |
| 1:247965730:G:A | M133I | 0.832 |
| 1:247965730:G:C | M133I | 0.832 |
| 1:247965730:G:T | M133I | 0.832 |
dbSNP variants (sampled 300 via entrez): RS1001008245 (1:247966320 A>G,T), RS1003403095 (1:247964171 C>T), RS1005234155 (1:247965280 T>A,C), RS1005522643 (1:247964462 A>G,T), RS1005986418 (1:247964195 A>G), RS1006240344 (1:247963766 A>G), RS1006904056 (1:247966383 G>T), RS1007330972 (1:247966661 T>C), RS1008522431 (1:247963255 C>G,T), RS1008774565 (1:247965970 A>C), RS1009599606 (1:247966686 A>T), RS1011829208 (1:247963630 T>C), RS1012275096 (1:247963412 C>T), RS1012907255 (1:247964502 C>T), RS1012997916 (1:247964125 C>A,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects cotreatment, increases methylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Fulvestrant | increases methylation, affects cotreatment | 1 |
| Copper | affects cotreatment, decreases expression | 1 |
| Phthalic Acids | increases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.